[Increasing transcutaneous PO2 in arteriopathies during treatment with PGE1 alpha-cyclodextrin].
Belcaro, G
[Increasing transcutaneous PO2 in arteriopathies during treatment with PGE1 alpha-cyclodextrin]. [electronic resource] - Minerva cardioangiologica Oct 1998 - 37-43 p. digital
Publication Type: English Abstract; Journal Article
0026-4725
Aged
Alprostadil--pharmacology
Arteriosclerosis--drug therapy
Cyclodextrins--pharmacology
Female
Gangrene--drug therapy
Humans
Intermittent Claudication--drug therapy
Ischemia--drug therapy
Leg--blood supply
Male
Oxygen
Partial Pressure
Vasodilator Agents--pharmacology
[Increasing transcutaneous PO2 in arteriopathies during treatment with PGE1 alpha-cyclodextrin]. [electronic resource] - Minerva cardioangiologica Oct 1998 - 37-43 p. digital
Publication Type: English Abstract; Journal Article
0026-4725
Aged
Alprostadil--pharmacology
Arteriosclerosis--drug therapy
Cyclodextrins--pharmacology
Female
Gangrene--drug therapy
Humans
Intermittent Claudication--drug therapy
Ischemia--drug therapy
Leg--blood supply
Male
Oxygen
Partial Pressure
Vasodilator Agents--pharmacology